• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.22% Nasdaq Up2.00%

    More On ABPI

    Quotes

    Charts

    News & Info

    Company

    • Profile
    • Key Statistics
    • SEC Filings
    • Competitors
    • Industry
    • Components

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Accentia Biopharmaceuticals, Inc. (ABPI)

    -Other OTC
    0.00 0.00(0.00%) Jan 6
    Analyst EstimatesGet Analyst Estimates for:
    Earnings EstCurrent Qtr.
    Jun 08
    Next Qtr.
    Sep 08
    Current Year
    Sep 08
    Next Year
    Sep 09
    Avg. EstimateN/AN/AN/AN/A
    No. of AnalystsN/AN/AN/AN/A
    Low EstimateN/AN/AN/AN/A
    High EstimateN/AN/AN/AN/A
    Year Ago EPS-0.71-0.33N/AN/A
    Revenue EstCurrent Qtr.
    Jun 08
    Next Qtr.
    Sep 08
    Current Year
    Sep 08
    Next Year
    Sep 09
    Avg. EstimateNaN22.10M47.76M72.06M
    No. of Analysts1111
    Low Estimate17.17M22.10M47.76M72.06M
    High Estimate17.17M22.10M47.76M72.06M
    Year Ago Sales3.76M4.08M18.28M47.76M
    Sales Growth (year/est)N/A441.30%161.20%50.90%
    Earnings HistoryJun 07Sep 07Dec 07Mar 08
    EPS Est-0.40-0.41-0.24-0.39
    EPS Actual-0.71-0.33-0.60-0.20
    Difference-0.310.08-0.360.19
    Surprise %-77.50%19.50%-150.00%48.70%
    EPS TrendsCurrent Qtr.
    Jun 08
    Next Qtr.
    Sep 08
    Current Year
    Sep 08
    Next Year
    Sep 09
    Current EstimateN/AN/AN/AN/A
    7 Days Ago0.03-0.29-1.050.10
    30 Days Ago0.03-0.29-1.050.10
    60 Days Ago0.03-0.29-1.050.10
    90 Days Ago0.03-0.29-1.050.10
    EPS RevisionsCurrent Qtr.
    Jun 08
    Next Qtr.
    Sep 08
    Current Year
    Sep 08
    Next Year
    Sep 09
    Up Last 7 Days0000
    Up Last 30 Days0000
    Down Last 30 Days0000
    Down Last 90 DaysN/AN/AN/AN/A
    Growth EstABPIIndustrySectorS&P 500
    Current Qtr.N/AN/A-68.40%7.70%
    Next Qtr.N/AN/AN/A15.20%
    This YearN/AN/A6.40%0.40%
    Next YearN/AN/A45.60%12.60%
    Past 5 Years (per annum)0.00%N/AN/AN/A
    Next 5 Years (per annum)N/A24.55%17.56%7.64%
    Price/Earnings (avg. for comparison categories)N/A-24.75-3.9715.65
    PEG Ratio (avg. for comparison categories)N/A-1.050.780.97
    Currency in USD.